BRIEF-Cynapsus therapeutics signs global licensing agreement with Monosol RX

Mon Apr 4, 2016 6:15am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

April 4 (Reuters) - Cynapsus Therapeutics Inc :

* Cynapsus Therapeutics and Monosol RX announce global IP licensing agreement

* Signed a global licensing agreement for certain intellectual property with Monosol RX

* Under agreement, Monosol RX will receive up front and contingent milestone payments, single-digit royalty payments on net sales of apl-130277 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)